Brandywine Pharmaceuticals, LLC recalls

All Brandywine Pharmaceuticals, LLC recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (2).

2 recalls published between November 4, 2026 and November 4, 2026. Most common issues: manufacturing practices (cgmp) (2).

• Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle… recall
  FDA November 4, 2026 · Brandywine Pharmaceuticals, LLC · Class II
• Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle… recall
  FDA November 4, 2026 · Brandywine Pharmaceuticals, LLC · Class II